LensGen
PrivateLast Round
Corporate Funding
Mar 2, 2023
Est. Valuation
$100M
Total Funding Raised
$41.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
LensGen is an ophthalmic medical device company that has developed a biomimetic, fluid-optic intraocular lens for the treatment of cataracts and presbyopia.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LensGen Comparables
Compare LensGen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Atia Vision | 93% | |
| Adaptilens | 90% | |
| JelliSee Ophthalmics Inc. | 89% | |
LensGen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Mar 2, 2023 | ||||
| Series B | Aug 20, 2020 | ||||
| Series A | May 1, 2017 |
LensGen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ExSight Ventures | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 55% MoM, from 826 to 1.3K.
- May 2, 2025
Monthly visitors grew 89% MoM, reaching 1.3K.
LensGen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about LensGen's valuation, stock price, and market status.